Cargando…

Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation

Background: The complement system activation and regulation have been linked to post-transplant pathologies including chronic antibody mediated rejection (cAMR) and the recurrence of IgA nephropathy (ReIgAN) but distinct mechanisms remain to be elucidated. Methods: In this retrospective single cente...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cernoch, Marek, Hruba, Petra, Kollar, Marek, Mrazova, Petra, Stranavova, Lucia, Lodererova, Alena, Honsova, Eva, Viklicky, Ondrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189372/ https://www.ncbi.nlm.nih.gov/pubmed/30356754 http://dx.doi.org/10.3389/fimmu.2018.02310

Ejemplares similares

A novel prognostic nomogram predicts premature failure of kidney allografts with IgA nephropathy recurrence
por: Bednarova, Kamila, et al.
Publicado: (2023)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
por: Maixnerova, Dita, et al.
Publicado: (2021)

Molecular Profiling of Acute and Chronic Rejections of Renal Allografts
por: Petra, Hřibová, et al.
Publicado: (2013)

Early isolated V-lesion may not truly represent rejection of the kidney allograft
por: Wohlfahrtova, Mariana, et al.
Publicado: (2018)

Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts
por: Trailin, Andriy, et al.
Publicado: (2021)

Complement in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2017)

Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy
por: Guo, Wei-yi, et al.
Publicado: (2022)

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021)

Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance
por: Krepsova, Eva, et al.
Publicado: (2015)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial
por: Viklicky, Ondrej, et al.
Publicado: (2017)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation
por: Stranavova, Lucia, et al.
Publicado: (2019)

Molecular insight in intrarenal inflammation affecting four main types of cells in nephrons in IgA nephropathy
por: Zhang, Haidong, et al.
Publicado: (2023)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category
por: Hruba, Petra, et al.
Publicado: (2020)

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
por: Sparding, Nadja, et al.
Publicado: (2021)

Intimal Arteritis and Microvascular Inflammation Are Associated With Inferior Kidney Graft Outcome, Regardless of Donor-Specific Antibodies
por: Novotny, Marek, et al.
Publicado: (2021)

Sepsis affects kidney graft function and one-year mortality of the recipients in contrast with systemic inflammatory response
por: Protus, Marek, et al.
Publicado: (2022)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022
por: Guo, Yun, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
por: Juan, Yun-Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8gdrdg2bp4cnjks86fcao5ah6